Hybrid transcatheter treatment of ischaemic heart failure: left ventricular volume reduction, scar exclusion and reshaping using the Revivent System for Less Invasive Ventricular Enhancement (LIVE)

With an unrestricted educational grant from BIOVENTRIX

Chairperson: J. Bartunek
Co-chairperson: C. Muneretto

Learning Objectives

  • To learn about the indications, imaging requirements and implantation techniques for the LIVE procedure for ischaemic heart failure patients
  • To hear updated 2-year clinical outcomes for Revivent surgical and Revivent transcatheter patients
  • To understand the added benefit the LIVE procedure has on ischaemic mitral valve regurgitation

Presentations available when logged in:

  • Session objectives
  • The Less Invasive Ventricular Enhancement procedure: which patients are indicated and how to perform it?
  • Revivent and Revivent transcatheter at 2-year follow-up
  • The impact of Revivent on ischaemic mitral regurgitation
  • Session evaluation and key learnings